Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KBAL
876
DELISTED
Kimball International
KBAL
| $17.7M | 0.02% |
1,075,191
+113,500
| +12% | +$1.9M |
|
|
FGL
877
DELISTED
Fidelity & Guaranty Life
FGL
| $17.7M | 0.02% |
636,657
+257,157
| +68% | +$6.63M |
|
|
HTO
878
H2O America
HTO
$2.62B
| $17.7M | 0.02% |
367,000
+53,300
| +17% | +$2.63M |
|
879
Central Garden & Pet Co
CENT
$2.79B
| $17.6M | 0.02% |
595,125
+74,625
| +14% | +$2.06M |
|
880
Vera Bradley
VRA
$96.7M
| $17.6M | 0.02% |
1,891,800
+498,950
| +36% | +$5.25M |
|
|
KMG
881
DELISTED
KMG Chemicals Inc
KMG
| $17.6M | 0.02% |
381,500
+21,300
| +6% | +$832K |
|
882
Enanta Pharmaceuticals
ENTA
$393M
| $17.5M | 0.02% |
567,693
-7,078
| -1% | -$220K |
|
883
Calix
CALX
$2.51B
| $17.5M | 0.02% |
2,411,600
+43,400
| +2% | +$307K |
|
884
Aaon
AAON
$7.03B
| $17.5M | 0.02% |
741,263
-49,800
| -6% | -$1.14M |
|
885
Essent Group
ESNT
$6.14B
| $17.5M | 0.02% |
482,800
-238,400
| -33% | -$8.28M |
|
886
Marvell Technology
MRVL
$195B
| $17.5M | 0.02% |
1,144,244
-1,351,191
| -54% | -$20.8M |
|
887
Blackstone Mortgage Trust
BXMT
$2.41B
| $17.4M | 0.02% |
563,180
+382,560
| +212% | +$11.8M |
|
|
BMS
888
DELISTED
Bemis
BMS
| $17.4M | 0.02% |
356,600
-76,400
| -18% | -$3.76M |
|
|
EXK
889
Endeavour Silver
EXK
$3.14B
| $17.4M | 0.02% |
5,476,800
+29,500
| +0.5% | +$115K |
|
890
Green Dot
GDOT
$766M
| $17.4M | 0.02% |
522,000
+99,200
| +23% | +$2.81M |
|
891
Fastenal
FAST
$59.9B
| $17.4M | 0.02% |
+1,350,976
| New | +$16.9M |
|
|
CLD
892
DELISTED
Cloud Peak Energy Inc
CLD
| $17.4M | 0.02% |
3,795,600
+996,600
| +36% | +$5.03M |
|
893
Kaiser Aluminum
KALU
$3.1B
| $17.4M | 0.02% |
217,300
-33,700
| -13% | -$2.68M |
|
894
Seacoast Banking Corp of Florida
SBCF
$3.44B
| $17.4M | 0.02% |
723,700
+27,700
| +4% | +$635K |
|
|
FBC
895
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $17.3M | 0.02% |
614,112
-264,500
| -30% | -$7.2M |
|
|
CDK
896
DELISTED
CDK Global, Inc.
CDK
| $17.3M | 0.02% |
265,900
-440,500
| -62% | -$28.2M |
|
|
AMAG
897
DELISTED
AMAG Pharmaceuticals
AMAG
| $17.3M | 0.02% |
766,000
+252,500
| +49% | +$6.05M |
|
898
Crane NXT
CXT
$2.99B
| $17.2M | 0.02% |
663,609
+213,621
| +47% | +$5.47M |
|
|
CHFN
899
DELISTED
Charter Financial Corp
CHFN
| $17.2M | 0.02% |
876,382
-23,877
| -3% | -$430K |
|
900
Hackett Group
HCKT
$278M
| $17.2M | 0.02% |
882,444
+359,300
| +69% | +$6.46M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.